TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 3.321 million compared to TWD 4.549 million a year ago. Operating loss was TWD 52.845 million compared to TWD 58.630 million a year ago. Net loss was TWD 72.177 million compared to TWD 54.079 million a year ago. Basic loss per share was TWD 0.1 compared to TWD 0.08 a year ago.